Updated:
AngioDynamics
AngioDynamics is a China-headquartered firm with offices in Beijing, Hong Kong, and Palo Alto.
AngioDynamics
AngioDynamics specializes in medical technologies and devices for vascular and oncology applications. Its products address conditions such as pulmonary embolism and chronic venous insufficiency. The company offers infusion therapies and percutaneous drainage solutions.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Additional offices
Hong Kong · Palo Alto, United States
Frequently asked questions
Where is AngioDynamics headquartered?
AngioDynamics lists its primary headquarters in Beijing, China, with additional offices in Hong Kong and Palo Alto, California (per the firm's website).
Who runs investment decisions at AngioDynamics?
No named principals or investment decision-makers are publicly associated with the firm. Its leadership structure is undisclosed.
What sectors does AngioDynamics invest in?
The firm does not publicly advertise any sector focus. Its website and public filings are quiet on targeted industries.
Is AngioDynamics a family office or an asset manager?
The firm's type is unclear from public sources. It is registered in China with multi-city offices, but no documentation specifies whether it operates as a family office, investment firm, or another entity.
Does AngioDynamics make direct investments or commit to funds?
No deal activity, fund commitments, or direct investments have been publicly reported. The firm's investment approach is unknown.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: